Biocon Limited has informed the Exchange regarding a press release dated December 28, 2020, titled "Biocon expands generic formulations portfolio with the launch of Tacrolimus capsules in the US".
Press Release Dec 28 2020
Filed with NSE ·
6ix hasn’t read this filing yet.
Earlier from Biocon
- Press Release Dec 15 2020
- Press Release Nov 07 2020
- Press Release Oct 30 2020
- Press Release Oct 23 2020
- Press Release Oct 08 2020
Later from Biocon
- Press Release Jan 07 2021
- Press Release Jan 21 2021
- Press Release Feb 04 2021
- Press Release Feb 16 2021
- Press Release Mar 01 2021
Follow Biocon into a list and get an email when it puts out news.
Follow Biocon